2-5A Ligands - A New Concept for the Treatment of Prostate Cancer

Author： Cramer Hagen   Okicki James   Rho Taikyun   Wang Xinning   Silverman Robert   Heston Warren  

Publisher： Taylor & Francis Ltd

ISSN： 1525-7770

Source： Nucleosides, Nucleotides & Nucleic Acids, Vol.26, Iss.10-12, 2007-10, pp. : 1471-1477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer

By Garofalo Antonio   Goossens Laurence   Lemoine Amelie   Farce Amaury   Arlot Yannick   Depreux Patrick  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 25, Iss. 2, 2010-04 ,pp. : 158-171

Informa Healthcare

Access to resources Recommend Favorite

Immunohistological detection of BRAF25 in human prostate tumor and cancer specimens

By Wang C.   McCarty I.M.   Balazs L.   Li Y.   Steiner M.S.  

Biochemical and Biophysical Research Communications, Vol. 295, Iss. 1, 2002-07 ,pp. : 136-141

Elsevier

Access to resources Recommend Favorite

Sipuleucel-T and immunotherapy in the treatment of prostate cancer

By Dawson Nancy A   Roesch Erin E  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 5, 2014-05 ,pp. : 709-719

Informa Healthcare

Access to resources Recommend Favorite

L-BLP25: a MUC1-targeted peptide vaccine therapy in prostate cancer

By Sangha Randeep   North Scott  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 11, 2007-11 ,pp. : 1723-1730

Informa Healthcare

Access to resources Recommend Favorite

Cadmium and cancer of prostate and testis

By Goyer Robert A.   Liu Jie   Waalkes Michael P.  

BioMetals, Vol. 17, Iss. 5, 2004-10 ,pp. : 555-558

Springer Publishing Company

Access to resources Recommend Favorite